Study how the brain clears amyloid in Alzheimer’s
Part of Brain & nervous system, Mental health clinical trials.
This trial studies how the brain removes amyloid-β, a protein linked to Alzheimer’s disease. It may help researchers understand what’s happening in people with mild memory impairment or Alzheimer’s, and guide better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with amnestic mild cognitive impairment, Alzheimer’s dementia, or you are clinically normal
- You can sign written consent yourself (or you must not need a legal guardian)
- Your medications have not changed in the 4 days before the study tests
- You are fluent in German
- You can safely do MRI (no MRI-incompatible implants, like certain pacemakers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET brain scan to look at two types of brain immune cells in people with Alzheimer’s. It may help researchers better understand Alzheimer’s and how these cells change over time.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
This study compares two types of brain PET scans (tau and amyloid) to see which one better helps diagnose memory problems. You may be eligible if you have mild cognitive impairment or mild dementia and your doctor has already ordered an amyloid PET scan.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This study uses a special PET scan to take pictures of abnormal tau protein in the brain. It aims to see if the scan results match what is found in brain tissue after death, which could help improve diagnosis of Alzheimer's and related conditions.
This study uses a special PET scan to look for inflammation in the brains of people with Alzheimer's or related dementias. It may help researchers understand how inflammation affects memory and thinking problems.
Hear when a new Alzheimer's Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.